The challenge for predicting bleeding events by assessing platelet reactivity following coronary stenting.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International Journal of Cardiology

• Publication date

  2016-03-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2016.01.102PMID 26800135
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Duration of Dual Antiplatelet Therapy After Coronary Stenting: A Review of the Evidence.

  2015cited by this paper
• Usefulness of thromboelastometry in predicting the risk of bleeding in cirrhotics who undergo invasive procedures

  2015cited by this paper
• Platelet Function Testing and Prediction of Bleeding in Patients Exposed to Clopidogrel Undergoing Coronary Artery Surgery

  2015cited by this paper
• Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention.

  2015cited by this paper
• Incidence of cardiovascular events and gastrointestinal bleeding in patients receiving clopidogrel with and without proton pump inhibitors: an updated meta-analysis

  2015cited by this paper
• Omeprazole, pantoprazole, and CYP2C19 effects on clopidogrel pharmacokinetic-pharmacodynamic relationships in stable coronary artery disease patients

  2015cited by this paper
• Predicting Bleeding Risk by Platelet Function Testing in Patients Undergoing Heart Surgery

  2015cited by this paper
• The role of point-of-care assessment of platelet function in predicting postoperative bleeding and transfusion requirements after coronary artery bypass grafting

  2015cited by this paper
• Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention.

  2015cited by this paper
• 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Ca

  2014cited by this paper
• 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous

  2014cited by this paper
• Optimizing P2Y12 receptor inhibition in patients with acute coronary syndrome on the basis of platelet function testing: impact of prasugrel and high-dose clopidogrel.

  2014cited by this paper
• Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysis.

  2013cited by this paper
• Platelet function tests in clinical cardiology: unfulfilled expectations.

  2013cited by this paper
• A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placem

  2012cited by this paper
• Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology.

  2011cited by this paper
• High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI.

  2011cited by this paper
• Standard- vs high-dose clopidogrel after percutaneous coronary intervention.

  2011cited by this paper
• Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.

  2011cited by this paper
• Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium

  2011cited by this paper
• Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data.

  2011cited by this paper
• Do platelet function analyzer-100 testing results correlate with bleeding events after percutaneous renal biopsy?

  2010cited by this paper
• High on‐aspirin platelet reactivity as measured with aggregation‐based, cyclooxygenase‐1 inhibition sensitive platelet function tests is associated with the occurrence of atherothrombotic events

  2010cited by this paper
• Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes.

  2009cited by this paper
• Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

  2009cited by this paper
• Prasugrel versus clopidogrel in patients with acute coronary syndromes.

  2007cited by this paper
• Clopidogrel resistance.

  2007cited by this paper
• A head‐to‐head comparison between the VerifyNow® P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention

  2006cited by this paper
• Clopidogrel resistance

  2004cited by this paper
• Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet Aggregation: A New Drug–Drug Interaction

  2003cited by this paper
• Does the platelet function analyser (PFA-100) predict blood loss after cardiopulmonary bypass?

  2003cited by this paper
• Resistance to thienopyridines: Clinical detection of coronary stent thrombosis by monitoring of vasodilator‐stimulated phosphoprotein phosphorylation

  2003cited by this paper
• Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study ☆

  2002cited by this paper
• Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.

  2001cited by this paper

• Effects of Body Mass Index and Body Weight on Plasma Concentration of Ticagrelor and Platelet Aggregation Rate in Patients with Unstable Angina in a Chinese Han Population

  2024cites this paper
• PROK2, HRNR, and FIG4 as potential genetic biomarkers of high bleeding propensity in East Asian patients with acute coronary syndrome using ticagrelor

  2022cites this paper
• Pharmacodynamic Profile and Prevalence of Bleeding Episode in East Asian Patients with Acute Coronary Syndromes Treated with Prasugrel Standard-Dose versus De-escalation Strategy: A Randomized A-MATCH Trial

  2021cites this paper
• Temporal Trends of Bleeding Episodes during Half- vs. Standard-Dose Ticagrelor in Acute Coronary Syndrome Patients with Low Platelet Reactivity: A Randomized BLEEDING-ACS Trial

  2021cites this paper
• The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease

  2020cites this paper
• [Antiplatelet agents and transfusion].

  2017cites this paper
• Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis.

  2017cites this paper
• Antiplaquettaires et transfusion

  2017cites this paper